Top Back to top

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Acute Leukemia Working Party (ALWP)
Study number:
2007-003514-34
Type of transplant:
 
Short title:
HSCT vs CT in Elderly AML
Study status:
Recruiting Patients
Deadline for data collection:
 
Study design:
Randomised, controlled, open, multicentre, phase III trial
Primary objective:
Efficacy of allogeneic related or unrelated heamtopoietic cell transplantation (HCT) after reduced intensityconditioning as a consolidation treatment for elderly patietns with AML in complete remission
Key inclusion criteria:
>=60, <=75 years old
Country:
Australia
Austria
Belgium
France
Germany
Netherlands
Switzerland
Principal investigator:
Dietger Niederwieser
Principal investigator email:
 
EBMT Study coordinator:
Ruzena Uddin